These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 8548373)
1. Degradation of bovine cartilage proteoglycan in vitro is enhanced by inhibition of nitric oxide synthase. Hanglow AC; Rowan K; Lusch L; Coffey JW Inflamm Res; 1995 Aug; 44 Suppl 2():S151-2. PubMed ID: 8548373 [No Abstract] [Full Text] [Related]
2. Zonal differences in nitric oxide synthesis by bovine chondrocytes exposed to interleukin-1. Fukuda K; Kumano F; Takayama M; Saito M; Otani K; Tanaka S Inflamm Res; 1995 Oct; 44(10):434-7. PubMed ID: 8564519 [TBL] [Abstract][Full Text] [Related]
3. Modulation of chondrocyte proteoglycan synthesis by endogeneously produced nitric oxide. Stefanovic-Racic M; Taskiran D; Georgescu HI; Evans CH Inflamm Res; 1995 Aug; 44 Suppl 2():S216-7. PubMed ID: 8548407 [No Abstract] [Full Text] [Related]
4. Interleukin-1 and oncostatin M in combination promote the release of collagen fragments from bovine nasal cartilage in culture. Cawston TE; Ellis AJ; Humm G; Lean E; Ward D; Curry V Biochem Biophys Res Commun; 1995 Oct; 215(1):377-85. PubMed ID: 7575616 [TBL] [Abstract][Full Text] [Related]
5. Modulation of IL-1-induced cartilage injury by NO synthase inhibitors: a comparative study with rat chondrocytes and cartilage entities. Cipolletta C; Jouzeau JY; Gegout-Pottie P; Presle N; Bordji K; Netter P; Terlain B Br J Pharmacol; 1998 Aug; 124(8):1719-27. PubMed ID: 9756389 [TBL] [Abstract][Full Text] [Related]
6. Nitric oxide and proteoglycan turnover in rabbit articular cartilage. Stefanovic-Racic M; Möllers MO; Miller LA; Evans CH J Orthop Res; 1997 May; 15(3):442-9. PubMed ID: 9246092 [TBL] [Abstract][Full Text] [Related]
7. Nitric oxide mediates suppression of cartilage proteoglycan synthesis by interleukin-1. Taskiran D; Stefanovic-Racic M; Georgescu H; Evans C Biochem Biophys Res Commun; 1994 Apr; 200(1):142-8. PubMed ID: 7513156 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of interleukin-1-induced proteoglycan degradation and nitric oxide production in bovine articular cartilage/chondrocyte cultures by the natural product, hymenialdisine. Badger AM; Cook MN; Swift BA; Newman-Tarr TM; Gowen M; Lark M J Pharmacol Exp Ther; 1999 Aug; 290(2):587-93. PubMed ID: 10411566 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of cartilage proteoglycan release by a specific inactivator of cathepsin B and an inhibitor of matrix metalloproteinases. Evidence for two converging pathways of chondrocyte-mediated proteoglycan degradation. Buttle DJ; Handley CJ; Ilic MZ; Saklatvala J; Murata M; Barrett AJ Arthritis Rheum; 1993 Dec; 36(12):1709-17. PubMed ID: 8250991 [TBL] [Abstract][Full Text] [Related]
12. S-substituted isothioureas are potent inhibitors of nitric oxide biosynthesis in cartilage. Jang D; Szabo C; Murrell GA Eur J Pharmacol; 1996 Oct; 312(3):341-7. PubMed ID: 8894617 [TBL] [Abstract][Full Text] [Related]
13. Use of arginine analogs as inhibitors of nitric oxide synthase in rat-aortic rings. Russell RJ Methods Mol Biol; 1998; 100():243-50. PubMed ID: 10907010 [No Abstract] [Full Text] [Related]
14. Matrix metalloproteinase inhibitor CGS 27023A protects COMP and proteoglycan in the bovine articular cartilage but not the release of their fragments from cartilage after prolonged stimulation in vitro with IL-1 alpha. Ganu V; Melton R; Wang W; Roberts D Ann N Y Acad Sci; 1999 Jun; 878():607-11. PubMed ID: 10415786 [No Abstract] [Full Text] [Related]
15. Selective inhibition of the activity of inducible nitric oxide synthase in septic shock. Thiemermann C Prog Clin Biol Res; 1995; 392():383-92. PubMed ID: 8524946 [No Abstract] [Full Text] [Related]
16. Reversibility of inhibition of human type II nitric oxide synthase. Nicholls DJ; Kirk A; Wallace AV Biochem Soc Trans; 1996 Feb; 24(1):20S. PubMed ID: 8674663 [No Abstract] [Full Text] [Related]
17. Nitric oxide (NO) and cartilage metabolism: NO effects are modulated by superoxide in response to IL-1. Jouzeau JY; Pacquelet S; Boileau C; Nedelec E; Presle N; Netter P; Terlain B Biorheology; 2002; 39(1-2):201-14. PubMed ID: 12082283 [TBL] [Abstract][Full Text] [Related]
19. The G1 domain of aggrecan released from porcine articular cartilage forms stable complexes with hyaluronan/link protein. Yasumoto T; Bird JL; Sugimoto K; Mason RM; Bayliss MT Rheumatology (Oxford); 2003 Feb; 42(2):336-42. PubMed ID: 12595632 [TBL] [Abstract][Full Text] [Related]
20. A synthetic peptide metalloproteinase inhibitor, but not TIMP, prevents the breakdown of proteoglycan within articular cartilage in vitro. Andrews HJ; Plumpton TA; Harper GP; Cawston TE Agents Actions; 1992 Sep; 37(1-2):147-54. PubMed ID: 1456176 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]